Alzheimer's Disease Stocks List

Recent Signals

Date Stock Signal Type
2019-09-20 AXIM Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-20 AXIM 50 DMA Support Bullish
2019-09-20 AXIM Upper Bollinger Band Walk Strength
2019-09-20 BIEI Narrow Range Bar Range Contraction
2019-09-20 BIEI 20 DMA Support Bullish
2019-09-20 BIEI Fell Below 50 DMA Bearish
2019-09-20 BIEI NR7 Range Contraction
2019-09-20 BIEI Calm After Storm Range Contraction
2019-09-20 BNOEF Crossed Above 20 DMA Bullish
2019-09-20 BNOEF Narrow Range Bar Range Contraction
2019-09-20 CBBT 20 DMA Resistance Bearish
2019-09-20 CBBT Narrow Range Bar Range Contraction
2019-09-20 CBBT Doji - Bullish? Reversal
2019-09-20 CBBT Stochastic Buy Signal Bullish
2019-09-20 CBBT Bollinger Band Squeeze Range Contraction
2019-09-20 CBBT Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-09-20 CGNSF Lower Bollinger Band Walk Weakness

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and gradually worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events. As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the typical life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be inherited from a person's parents with many genes usually involved. Other risk factors include a history of head injuries, depression, and hypertension. The disease process is associated with plaques and neurofibrillary tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD; however, evidence to support these recommendations is weak. There are no medications or supplements that have been shown to decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver. The pressures can include social, psychological, physical, and economic elements. Exercise programs may be beneficial with respect to activities of daily living and can potentially improve outcomes. Behavioural problems or psychosis due to dementia are often treated with antipsychotics, but this is not usually recommended, as there is little benefit with an increased risk of early death.In 2015, there were approximately 29.8 million people worldwide with AD. It most often begins in people over 65 years of age, although 4–5% of cases are early-onset Alzheimer's. It affects about 6% of people 65 years and older. In 2015, dementia resulted in about 1.9 million deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.

More about Alzheimer's Disease